CDC-RFA-CE20-2004CC21: Drug-Free Communities (DFC) Support Program – Competing Continuation
Closed
This grant is closed. A newer notice from the same program is forecast: Drug-Free Communities (DFC) Support Program – Competing Continuation (Year 6) (CDC-RFA-CE22-22050601CONT27). Status: Expected deadline March 31, 2027. It is in our archive of Centers for Disease Control - NCIPC notices from 2021.
Centers for Disease Control - NCIPC offered grants of up to $125,000 to any type of organization. It expected to make about 100 awards worth $62.5 million in total. Applications closed on May 26, 2021.
From the official notice on Grants.gov, last changed April 14, 2021. Checked November 7, 2026.
- Award ceiling$125,000
- Total funding$62.5 million
- Expected awards100
- Cost sharingRequired
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| CDC-RFA-CE20-2004CC22 | February 9, 2022 | Closed April 11, 2022 | Closed |
Key dates
| Posted | March 26, 2021 |
|---|---|
| Deadline | May 26, 2021 |
| Archived by Grants.gov | June 25, 2021 |
Who can apply
This opportunity was open to any type of organization.
All 12 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Eligible applicants are community-based coalitions addressing youth substance use that have previously received a DFC grant but have experienced a lapse in funding or have concluded the first five-year funding cycle and are applying for a second five-year funding cycle (Year 6). Statutory Eligibility Requirements, written into the DFC Act, are inherent in the language of the DFC Support Program. Applicants should refer to Table 3: Statutory Eligibility Requirements, which contains a summary of the minimum documentation applicants must provide to meet these criteria. The table also specifies evidence required and where to place it in the application, e.g., as an attachment, in the Project Narrative, or in the Budget. Failure to meet any single statutory eligibility requirement will cause the application to be deemed ineligible; in such case, it will not move forward to merit review. Should your application fail to meet the eligibility requirements, the person listed as the Business Official on the Application for Federal Assistance (SF-424) will receive a notification stating why the application was deemed ineligible. No additional information may be added to an application after the application deadline. The final authority lies with the DFC Administrator to determine the eligibility of an application. All DFC applications will be jointly screened by ONDCP and CDC to determine whether an applicant meets all the DFC Support Program Statutory Eligibility Requirements identified in Table 3. Applications submitted by eligible coalitions that demonstrate they meet all requirements will then be scored through a merit review process according to the evaluation criteria described in Section V. Application Review Information of this NOFO. Each year, DFC recipients must demonstrate compliance with all of the Statutory Eligibility Requirements to be considered for continuation funding. NOTE: Coalitions that have already received 10 years of DFC funding are not eligible to apply for this grant. A DFC legal applicant (an organization applying on behalf of a coalition, the coalition, or the applicant coalition) must reside within the United States and/or the U.S. territories. The intent of the DFC Support Program is to fund coalition activities in the United States and does not authorize the funding of organizations or activities outside the United States.
Is this a realistic fit?
- Past Drug-Free Communities Support Program Grants awards averaged $312,548; this notice allows up to $125,000 per award.
- Most of the program's money (71% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The Drug-Free Communities (DFC) Support Program was created by the Drug-Free Communities Act of 1997 (Public Law 105-20). The Executive Office of the President, Office of National Drug Control Policy (ONDCP), and the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC), Drug-Free Communities Branch are accepting applications for Fiscal Year (FY) 2021 Drug-Free Communities (DFC) Support Program grants. By statute, the DFC Support Program has two goals: 1) Establish and strengthen collaboration among communities, public and private non-profit agencies, as well as federal, state, local, and tribal governments to support the efforts of community coalitions working to prevent and reduce substance abuse among youth (individuals 18 years of age and younger). 2) Reduce substance abuse among youth and, over time, reduce substance abuse among adults by addressing the factors in a community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse.
Who has won Drug-Free Communities Support Program Grants grants before
From fiscal 2021 to 2025, Drug-Free Communities Support Program Grants (93.276) awarded $500 million across 1,600 grant awards, an average of $312,548 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| BD of Education Oakland Co Milford Twp | Michigan | 2 | $1.1 million |
| Graham County Substance Abuse Coalition | Arizona | 3 | $1.0 million |
| Mosaic Community Services, Inc | Maryland | 3 | $876,911 |
| Mansfield-Richland | Ohio | 2 | $875,000 |
| RWJBH Behavioral Health, Prevention and Recovery, Inc. | New Jersey | 4 | $864,099 |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-CE22-22050601CONT27, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CE20-2004CC21 still open?
No. It closed on May 26, 2021. A newer notice is forecast: CDC-RFA-CE22-22050601CONT27, expected deadline March 31, 2027.
Who can apply for Drug-Free Communities (DFC) Support Program – Competing Continuation?
Centers for Disease Control - NCIPC accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Drug-Free Communities (DFC) Support Program – Competing Continuation?
Closed May 26, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $125,000 each. About $62.5 million in total across about 100 awards.
Who has won Drug-Free Communities Support Program Grants grants before?
The largest recipients over five fiscal years were BD of Education Oakland Co Milford Twp, Graham County Substance Abuse Coalition, Mosaic Community Services, Inc. The program made 1,600 awards worth $500 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)